医学
药品定价
药方
处方药
药品
重症监护医学
药理学
精算学
业务
作者
Thomas J. Hwang,Aaron S. Kesselheim,Benjamin N. Rome
出处
期刊:JAMA
[American Medical Association]
日期:2022-08-19
卷期号:328 (11): 1041-1041
被引量:23
标识
DOI:10.1001/jama.2022.15268
摘要
This Viewpoint describes the provisions and limitations of prescription drug pricing reforms enacted by US Congress as part of the Inflation Reduction Act in August 2022.
科研通智能强力驱动
Strongly Powered by AbleSci AI